Highlights the importance of a structured approach to managing warfarin therapy to address non-adherence and factors affecting drug effectiveness in atrial fibrillation patients.
Answers are grounded in this paper and cite their sources.
Supports structured warfarin management to address adherence barriers in practice; hypothesis-generating and requires validation in larger studies.
Atrial fibrillation (AF) is a major risk factor for stroke, requiring monitoring and treatment. If there are no significant risk factors, warfarin therapy may be prescribed for some types of AF, but necessitates compliance, careful monitoring and dose adjustment. Many factors influence the effectiveness of warfarin therapy, including alcohol consumption, dietary constituents, herbal supplements, and prescribed or over-the-counter medicines. Compliance, in turn, can be affected by factors such as the presence of dementia or cognitive impairment. As exemplified in this case study, a structured approach for the management of warfarin should be adopted, ensuring factors affecting compliance or drug effectiveness may be identified and appropriate action can be taken.
No takes yet. Share an insight, caveat, or question.
Natasha Duke (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: